However, approximately 30% of all Finnish ALS patients have p.D91A mutation, and the p.A5V accounts for almost half in SOD1 mutations in the United States (Bali et al., 2017; Korpi et al., 2020). The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.